118 related articles for article (PubMed ID: 428616)
1. Managing chronic skin conditions with two differing topical corticosteroids.
Woodbridge PA; Sparkes CG
Dermatologica; 1979; 158(4):299-306. PubMed ID: 428616
[TBL] [Abstract][Full Text] [Related]
2. Topical corticosteroids.
Möller H
Int J Dermatol; 1989 May; 28(4):279. PubMed ID: 2722349
[No Abstract] [Full Text] [Related]
3. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
Jegasothy B; Jacobson C; Levine N; Millikan L; Olsen E; Pinnell S; Cole G; Weinstein G; Porter M
Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
[TBL] [Abstract][Full Text] [Related]
4. Topical clobetasol-17-propionate: review of its clinical efficacy and safety.
Olsen EA; Cornell RC
J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):246-55. PubMed ID: 3528243
[TBL] [Abstract][Full Text] [Related]
5. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
Svartholm H; Larsson L; Frederiksen B
Curr Med Res Opin; 1982; 8(3):154-7. PubMed ID: 6751703
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with 0.05% clobetasol propionate creams.
Richards RN
J Am Acad Dermatol; 1985 May; 12(5 Pt 1):891-3. PubMed ID: 4008693
[No Abstract] [Full Text] [Related]
7. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison between two new topical corticosteroids, halcinonide 0.1% and clobetasol propionate cream 0.05%.
Bleeker J
Curr Med Res Opin; 1975; 3(4):225-8. PubMed ID: 1097198
[TBL] [Abstract][Full Text] [Related]
9. Halogenation and topical corticosteroids: a comparison between the 17-butyrate esters of hydrocortisone and clobetasone in ointment bases.
Allenby CF; Sparkes CG
Br J Dermatol; 1981 Feb; 104(2):179-83. PubMed ID: 7011356
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of clobetasol dipropionate and betamethasone dipropionate].
Rozzoni M; Tribbia G; Reseghetti A; Bassi R
G Ital Dermatol Venereol; 1982; 117(5):LXV-LXIX. PubMed ID: 6764916
[No Abstract] [Full Text] [Related]
11. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
[No Abstract] [Full Text] [Related]
12. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
Telfer NR; Dawber RP
J Am Acad Dermatol; 1987 Jul; 17(1):144-5. PubMed ID: 3611449
[No Abstract] [Full Text] [Related]
13. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
14. The use and abuse of 0.05 per cent clobetasol propionate in dermatology.
Harris DW; Hunter JA
Dermatol Clin; 1988 Oct; 6(4):643-7. PubMed ID: 3229014
[TBL] [Abstract][Full Text] [Related]
15. Potent topical steroids and psoriasis.
Sandoval Cruz M; Moncada B
J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):387. PubMed ID: 3346427
[No Abstract] [Full Text] [Related]
16. Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis.
Griffiths CE; Powles AV; Baker BS; Fry L; Valdimarsson H
Transplant Proc; 1988 Jun; 20(3 Suppl 4):50-2. PubMed ID: 3381302
[No Abstract] [Full Text] [Related]
17. Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate.
Möller H; Svartholm H; Dahl G
Curr Med Res Opin; 1983; 8(9):640-4. PubMed ID: 6365465
[TBL] [Abstract][Full Text] [Related]
18. Clobetasol--a potent new topical corticosteroid.
Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
[No Abstract] [Full Text] [Related]
19. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
[TBL] [Abstract][Full Text] [Related]
20. Atrophic skin striae following the use of clobetasol propionate ointment.
Hardie RA; Waring AJ; Barnetson RS
Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
[No Abstract] [Full Text] [Related]
[Next] [New Search]
